ClinVar Miner

Submissions for variant NM_022041.4(GAN):c.806G>A (p.Arg269Gln)

gnomAD frequency: 0.00001  dbSNP: rs759581558
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000623340 SCV000742819 pathogenic Inborn genetic diseases 2017-08-02 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000789766 SCV004035998 uncertain significance Giant axonal neuropathy 1 2023-01-26 criteria provided, single submitter clinical testing The GAN c.806G>A (p.Arg269Gln) missense variant results in the substitution of arginine at amino acid position 269 with glutamine. This variant has been reported in a homozygous state in two siblings with giant axonal neuropathy from reportedly non-consanguineous parents from the same village (PMID: 12655563). A different amino acid change at the same position, c.805C>T (p.Arg269Trp), was also reported in a compound heterozygous state with a missense variant of unknown significance in an affected female with an atypical giant axonal neuropathy phenotype (PMID: 23248352). The c.806G>A variant is reported in the Genome Aggregation Database in three alleles at a frequency of 0.000011 in the total population (version 2.1.1). Based on the available evidence, the c.806G>A (p.Arg269Gln) variant is classified as a variant of uncertain significance for giant axonal neuropathy.
Concord Molecular Medicine Laboratory, Concord Repatriation General Hospital RCV000789766 SCV004562016 likely pathogenic Giant axonal neuropathy 1 2024-02-14 criteria provided, single submitter clinical testing This variant is detected in homozyous state in a patient with a clinical diagnosis of giant axonal neuropathy, with the typical associated fizzy hair. This variant is present at extremely low frequency in population database (gnomAD v4 0.0005%). It has been reported in two siblings in a homozygous state with giant axonal neuropathy (PMID: 12655563). In silico analysis predicts this variant to be damaging (REVEL 0.78). A different amino acid change at the same position, p.(Arg269Trp), was also reported in a compound heterozygous state in patients with GAN-related conditions (PMID: 23248352, 23890932, 32999401).
Inherited Neuropathy Consortium RCV000789766 SCV000929147 likely benign Giant axonal neuropathy 1 no assertion criteria provided literature only
Inherited Neuropathy Consortium Ii, University Of Miami RCV000789766 SCV004174498 uncertain significance Giant axonal neuropathy 1 2016-01-06 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.